This scrip has fully corrected, bottomed out and has made a double bottom. Now it is poised to rise, as its USA sales have become stabilised with low prices of generic medicine acceptable to them. Buy and hold on for reaping good benefits.
Comments
traderparag
⋅
It appears to be heading in the right direction already - Nice!